Portable Neuromodulation Stimulator (PoNS®) Therapy for Gait and Balance Deficits in Chronic Stroke Survivors: A Randomized Controlled Trial.

NAActive, not recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 12, 2024

Primary Completion Date

July 30, 2025

Study Completion Date

September 30, 2025

Conditions
Chronic Stroke Survivors
Interventions
DEVICE

Portable Neuromodulation Stimulator (PoNS)

The PoNS device does not deliver stimulation produced by amplitude-controlled, biphasic pulses to the anterior superior surface of the tongue through gold-plated electrodes plus physical therapy.

DEVICE

Portable Neuromodulation Stimulator (PoNS)

The PoNS device delivers stimulation produced by amplitude-controlled, biphasic pulses to the anterior superior surface of the tongue through gold-plated electrodes plus physical therapy.

Trial Locations (3)

T2G 3A5

Synaptic Health, Calgary

N6J 2K4

Neuphysio, London

H4H1M5

Neuro-Concept, Verdun

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Helius Medical Inc

INDUSTRY

NCT06470009 - Portable Neuromodulation Stimulator (PoNS®) Therapy for Gait and Balance Deficits in Chronic Stroke Survivors: A Randomized Controlled Trial. | Biotech Hunter | Biotech Hunter